Clinical Trial Update: Efficacy of Pramipexole Extended Release in the Treatment of Essential Tremor [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pramipexole extended-release for essential tremor was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• Pramipexole Extended Release (pramipexole)

Snippet

Sponsor: University of Pecs | Conditions: Essential Tremor | Phase 3 | Status: WITHDRAWN